Biochemical evaluation of hyaluronic acid in breast cancer

Clinical Laboratory

Volumn 60, Issue 7, 2014, Pages 1115-1121

  Yahya, Raida Said ^a   El Bindary, Ashraf A ^b   El Mezayen, Hatem A ^c   Abdelmasseh, Hanaa M ^d   Eissa, Mohammed A ^e  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b DAMIETTA UNIVERSITY   (Egypt)

^c Helwan University   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

^e Damiette Cancer Institute   (Egypt)

Author keywords

Breast cancer; Extra cellular matrix; Glucosamine; Glucuronic acid; Hyaluronic acid; Hyaluronidase; N acetyl D glucosminidase and glucuronidas

Indexed keywords

BREAST NEOPLASMS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYALURONIC ACID;

EID: 84905040558     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.130413     Document Type: Article

References (37)

1. Anan K, Mitsuyama S, Tamae K, Suchara N, Vishihara K, Ogawa Y. Postoperative follow up of patients with early breast cancer: reappraisal of serum tumor markers. Surg Today 2002;32:13-8. (Pubitemid 34119040)
2. Auvinen P, Tammi R, Parkkinen J, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000;156:529-36. (Pubitemid 30643808)
3. Boas NF. Method for the determination of hexosamines in tissues. J Biol Chem 1953;204(2):553-63.
4. Enegd B, King JA, Stylli S, Paradiso L, Kaye AH. Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery 2002;50:1311-8. (Pubitemid 36322773)
5. Fjeldstad K, Kolset SO. Decreasing the metastatic potential in cancers - targeting the heparan sulfate proteoglycans. Curr Drug Targets 2005;6:665-82. (Pubitemid 41236550)
6. Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006;66:10233-7. (Pubitemid 44799736)
7. Hayen W, Goebeler M, Kumar S, Riessen R, Nehls V. Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci 1999;112 2241-51. (Pubitemid 29355439)
8. Huttere F. Degradation of mucopolysaccharides by hepatic lysosomes. Biochem Biophys Acta 1966;115:312-9.
9. Jemal A, Bray F, Melissa M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61(2):69-90.
10. Khaldoyanidi SK, Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using hyaluronic acid. Patent Publication Nr: US20060069064 A1.
11. Kim HW, Mino K, Ishikawa K. Crystallization and preliminary X-ray analysis of endoglucanase from Pyrococcus horikoshii. Acta Crystallogr Sect F Struct Biol Cryst Commune 2008;64(Pt 12):1169-71.
12. Knudson W, Biswas C, Toole BP. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci USA 1984;81:6767-71. (Pubitemid 15221001)
13. Li Y, Li L, Brown TJ, Heldin P. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 2007;120:2557-67. (Pubitemid 46651275)
14. Lin G, Stern R. Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Lett 2001;163:95-101. (Pubitemid 32121834)
15. Lokeshwar VB, Selzer MG. Differences in hyaluronic acid-mediated functions and signaling in arterial, micro vessel, and vein-derived human endothelial cells. J Biol Chem 2000;275:27641-9.
16. Lokeshwar VB, Obek C, Pham HT, Wei D, Young MJ. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol 2000;163:348-56.
17. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 2001;276:11922-32.
18. Michell RH, Karnovsky MJ, Karnovsky ML. The distributions of some granule-associated enzymes in guinea-pig polymorphonuclear leucocytes. Biochem J 1970;116(2):207-16.
19. Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M. Tumor markers in breast cancer: European Group of Tumor Markers (EGTM) recommendations. Tumor Biol 2005;26:281-93. (Pubitemid 41619458)
20. Nir I. Determination of Glucuronic acid by naphthoresorcinol method. Anal Biochem 1964;8:20-3.
21. Pirinen R, Tammi R, Tammi M, Hirvikoski P, Parkkinen JJ. Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 2001;95:12-7.
22. Pugh D, Leaback DH, Walker PG. Studies on glucosaminidase; N-acetyl-beta-glucosaminidase in rat kidney. Biochem J 1957;65:464-9.
23. Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumor neo vascularization (review). Int J Cancer 1995;60,632-6.
24. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 1998;58:342-7. (Pubitemid 28047077)
25. Said AFM, Abulkheir IIH, Helal A, Mohammad DB. Detection of CK 19 mRNA in the blood of breast cancer female Egyptian patients and its relation to established prognostic parameters. Life Science Journal 2012;9(1):561-71.
26. Simpson MA, Lokeshwar VB. Hyaluronan and hyaluronidase in genitourinary tumor. Front Bioscience 2008;13:5661-80.
27. Slevin M, Krupinski J, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998;78:987-1003. (Pubitemid 28378213)
28. Soltes L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J. Degradative action of reactive oxygen species on hyaluronan. Bio macromolecules 2006;7:659-68.
29. Suwiwat S, Ricciardelli C, Tammi R, et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 2004;10:2491-8. (Pubitemid 38445711)
30. Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Biol Chem 2002;277:4581-4. (Pubitemid 34968482)
31. Tan JX, Wang XY, Li HY, Su XL, Wang L. HYAL1 over expression is correlated with the malignant behavior of human breast cancer. Int J Cancer 2011;128:1303-15.
32. Toole BP. Hyaluronan promotes the malignant phenotype. Glycobiology 2002;12:37R-42R. (Pubitemid 34567859)
33. Udabage L, Brownlee GR, Stern R, Brown TJ. Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: an in vitro and in vivo study. Glycoconj J 2004;20:461-71. (Pubitemid 43014140)
34. Wang XY, Tan JX, Vasse M, Delpech B, Ren GS. Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro. Chin Med J 2009;122:1300-4.
35. Wernicke M, Pineiro LC, Caramutti D, et al. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol 2003;16:99-107. (Pubitemid 36245740)
36. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996;313:17-29. (Pubitemid 26013419)
37. Xu X, Ziegler RG, Waterhouse DJ, Saavedra JE, Keefer LK. Stable isotope dilution high-performance liquid chromatography-electrospray ionization mass spectrometry method for endogenous 2- and 4-hydroxyestrones in human urine. J Chromatograph B Analyt Technol Biomed Life Sci 2002;780,315-30. (Pubitemid 35223568)